Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (202)	4/29/1998 5:58:00 PM
From: Richard Haugland	Read Replies (1) \| Respond to of 3044

Millennium Reports First Quarter 1998 Financial Results CAMBRIDGE, Mass., April 29 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news), today reported consolidated financial results for the first quarter ended March 31, 1998. Revenues under the Company's strategic alliances increased to $21,043,000 for the first quarter of 1998 compared to $10,956,000 for the first quarter of 1997. The net loss for the first quarter of 1998 was $4,426,000, or basic net loss per share of $0.15, compared to a net loss of $87,419,000 or basic net loss per share of $3.29, for the quarter ended March 31, 1997. Included in the net loss for the first quarter of 1997 was a one-time charge of $83,800,000 for acquired in-process research and development related to the ChemGenics Pharmaceuticals Inc. acquisition. Excluding the one-time charge, the net loss for the first quarter of 1997 was $3,619,000, or basic net loss per share of $0.14. Expenditures on research and development for the first quarter of 1998 were $22,429,000 versus $11,600,000 for the first quarter of 1997. As of March 31, 1998, Millennium had over $86 million in cash, cash equivalents and investments. biz.yahoo.com The projected loss was 24 cents so MLNM "beat" earnings by quite a bit. Revenues double over last year, although these fluctuate a lot with payments timing. IMO, looks good.